Results 241 to 250 of about 93,647 (322)

A Pilot Epigenome-Wide Study of Posttraumatic Growth: Identifying Novel Candidates for Future Research. [PDF]

Epigenomes
Rubens M, Pinto PR, Sathyanarayanan A, Miller O, Mullens AB, Bruenig D, Obst P, Shakespeare-Finch J, Mehta D.   +8 more
europepmc   +1 more source

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents

Márcia S. Pereira, Maria Teresa Cruz, Ana Fortuna, Joana Bicker   +3 more
openalex   +1 more source

MOESM3 of A comprehensive epigenome map of Plasmodium falciparum reveals unique mechanisms of transcriptional regulation and identifies H3K36me2 as a global mark of gene suppression

, 2015
Krishanpal Karmodiya, Saurabh Pradhan, Bhagyashree S. Joshi, Rahul Jangid, Puli Chandramouli Reddy, Sanjeev Galande   +5 more
openalex   +1 more source

Nanobiotechnology‐Based Approaches for Targeted Glioma Therapy

Advanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
Nanoparticle systems cross the blood–brain barrier to deliver drugs precisely to glioma cells. Lipid, polymeric, and magnetic carriers enable controlled release, tumor targeting, and microenvironment modulation. These nanoplatforms enhance chemotherapy, radiotherapy, and immunotherapy, improving therapeutic efficacy while reducing systemic toxicity ...
Jinwei Li, Yibo He, Yang Zhang, Lining Arnold Ju, Yao Wang, Jianxuan Zhou, Yinying Chai, Xuhui Hui, ShiYuan Tong, Si Zhang, Yanli Tan, Yinyan Wang   +11 more
wiley   +1 more source

An epigenome-wide association study in the case-control study to explore early development identifies differential DNA methylation near ZFP57 as associated with autistic traits [PDF]

Ellen M. Howerton, Valerie N. Morrill, Rose Schrott, Jason Daniels, Ashley Song, Kelly S. Benke, Heather E. Volk, Homayoon Farzadegan, Aimee Alexander, Amanda L. Tapia, Gabriel S. Dichter, Lisa Croen, Lisa D. Wiggins, Genevieve L. Wojcik, M. Daniele Fallin, Christine Ladd‐Acosta   +15 more
openalex   +1 more source

Enzymatically Synthesized Poly(Gallic Acid) Modulates Methionine Synthase Activity and Neuroblastoma Morphology in Contrast to Phthalate‐Type Endocrine Disruptors

Biopolymers, Volume 117, Issue 1, January 2026.
ABSTRACT The effect of the enzyme‐mediated poly(gallic acid) (PGAL) as a potential redox regulator or redox activity compound (RAC) on the morphology of human neuroblastoma SH‐SY5Y cells and its methionine synthase (MS) activities is contrasted to those for disrupting compounds (EDC).
Gabriela García‐Cerón, Iván H. Bello‐Cortés, Yazmín Ramiro‐Cortés, Manuel Gutiérrez‐Aguilar, Marcos Rosetti Sciutto, Francisco Sánchez‐Bartéz, Miquel Gimeno, Roeb García‐Arrazola   +7 more
wiley   +1 more source

Reconstructing epigenomic dynamics through a single-cell multi-epigenome data integration framework. [PDF]

Nat Commun
Fujii T, Tomimatsu K, Kato M, Ito M, Sato S, Kurumizaka H, Sato Y, Maehara K, Kimura H, Harada A, Ohkawa Y.   +10 more
europepmc   +1 more source

Estimating population structure using epigenome-wide methylation data [PDF]

Ziqing Wang, Kent D. Taylor, Jerome I. Rotter, Stephen S. Rich, Yinan Zheng, Lifang Hou, Xiuqing Guo, Jan Bressler, Laura M. Raffield, Yongmei Liu, Robert C. Kaplan, Donald Lloyd-Jones, Alanna C. Morrison, Myriam Fornage, Tamar Sofer   +14 more
openalex   +1 more source

Comprehensive Mapping of Functional Enhancers in Chinese Hamster Ovary Cells

Biotechnology and Bioengineering, Volume 123, Issue 1, Page 196-211, January 2026.
In this study, the authors identified regions with enhancer activity in the CHO cell genome using genome‐wide and targeted STARR‐seq. The analysis revealed thousands of newly identified enhancer sequences, where some of the most active sequences could drive transgene expression at levels similar to or higher than strong viral enhancers.
María Santos, Yusuf B. Johari, Laura Biggins, Natalie C. Elliott, Stefan Schoenfelder, Mounika Boddireddy, Daniel K. Fabian, Michael Anbar, Peter M. O'Callaghan, Peter J. Rugg‐Gunn   +9 more
wiley   +1 more source

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Metastatic melanoma is the most lethal form of skin cancer, accounting for most skin cancer‐related deaths. Immunotherapies and targeted therapies have improved overall and progression‐free survival rates in metastatic melanoma patients. The effectiveness of these therapies decreases due to multidrug resistance (MDR).
Jacqueline Maphutha, Danielle Twilley, Mona Dawood, Thomas Efferth, Namrita Lall   +4 more
wiley   +1 more source